BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12479578)

  • 1. Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression.
    van Bilsen M; van der Vusse GJ; Gilde AJ; Lindhout M; van der Lee KA
    Mol Cell Biochem; 2002 Oct; 239(1-2):131-8. PubMed ID: 12479578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.
    Gilde AJ; Van Bilsen M
    Acta Physiol Scand; 2003 Aug; 178(4):425-34. PubMed ID: 12864748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.
    Lazennec G; Canaple L; Saugy D; Wahli W
    Mol Endocrinol; 2000 Dec; 14(12):1962-75. PubMed ID: 11117527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
    Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
    Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
    Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
    Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J; Wagner JA
    Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors: from genes to physiology.
    Kliewer SA; Xu HE; Lambert MH; Willson TM
    Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation.
    Blanquart C; Barbier O; Fruchart JC; Staels B; Glineur C
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):267-73. PubMed ID: 12943712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
    Kawada T
    Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of action of PPARs.
    Berger J; Moller DE
    Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
    Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T
    Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.